North America was the largest region in the genito-urinary drugs market in 2017, accounting for around 39% market share. This can be attributed to the robust healthcare infrastructure, awareness and technological advancements in manufacturing of genitourinary drugs. Asia Pacific was the second largest region accounting for around 20% market share. Western Europe was the third largest region accounting for around 17% market share.
Genito-urinary Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs sector.
Genito-urinary Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the genito-urinary drugs market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the genito-urinary drugs market and suggests approaches.
Reasons To Purchase
- Fully updated for 2018.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
Markets Covered: Hormonal contraceptives, Drugs For Hormonal Replacement Therapy, Drugs For Infections And Others, Drugs for Benign prostatic hypertrophy, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs for Infertility, and Diuretics
Companies Mentioned: Daiichi Sankyo Company Limited, Pfizer Inc., Bayer AG, Astellas Pharma Inc., Allergan Plc., Otsuka Pharmaceutical Co., Ltd., GlaxosmithKline Plc., Sanofi S.A.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
Table of Contents
Genito-urinary Drugs Market Characteristics 5
Genito-urinary Drugs Market Historic Growth (2013-17) 7
Genito-urinary Drugs Market Forecast Growth (2017-21) 8
Genito-urinary Drugs Market Segmentation 10
Global Genito-urinary Drugs Market, Split By Segments, 2017, $ Billion 10
Hormonal Contraceptives 11
Drugs For Hormonal Replacement Therapy 11
Drugs For Infections And Others 11
Global Genito-urinary Drugs Market, Historic and Forecast, Split By Segments, 2013-2021 12
Genito-urinary Drugs Market Geography Regional and Country Comparison 14
Global Genito-urinary Drugs Market, Split By Regions, 2017 14
Global Genito-urinary Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021 16
Global Genito-urinary Drugs Market, Split By Country, 2017 18
Global Genito-urinary Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021 20
Genito-urinary Drugs Market Competitive Landscape 22
Daiichi Sankyo Company, Limited 23
Pfizer Inc. 23
Bayer AG 23
Astellas Pharma Inc 23
Allergan Plc. 23
Otsuka Pharmaceutical Co., Ltd. 23
GlaxosmithKline Plc. 23
Sanofi S.A. 23
Daiichi Sankyo Company Limited 24
Bayer AG 25
Genito-urinary Drugs Market Key Mergers And Acquisitions 26
Valeant Pharmaceuticals Acquired Sprout Pharmaceuticals 26
Adamis Pharmaceuticals Acquired US Compounding 26
Norgine Acquired Merus Labs 26
Astellas Acquired Ogeda 26
Genito-urinary Drugs Market Trends and Strategies 27
Demand For Combination Products 27
Increasing Demand For Low-Cost Erectile Dysfunction Drugs 27
Increase In Mergers And Acquisitions 27
Increase In The Approvals Of Novel Drugs 27
Definition Of Market Covered In This Report 28
Research Methodology 28
Research Inquiries 29
The Business Research Company 29
List of Figures
Figure 1: Global Genito-urinary Drugs Market, Historic Market Size, 2013-2017, $ Billion 7
Figure 2: Global Genito-urinary Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion 8
Figure 3: Global Genito-urinary Drugs Market, Split By Segments, 2017, $ Billion 10
Figure 4: Global Genito-urinary Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021 12
Figure 5: Global Genito-urinary Drugs Market, Split By Region, 2017, $ Billion 14
Figure 6: Global Genito-urinary Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021 16
Figure 7: Global Genito-urinary Drugs Market, Split By Country, 2017, $ Billion 18
Figure 8: Global Genito-urinary Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021 20
Figure 9: Global Genito-urinary Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%) 22
The Business Research Company
47 Anchorage Point,
42 Cuba Street, Canary Wharf,
+44 207 1930 708